Charles River Laboratories CRL Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $995.83M+1.2% | $994.23M-0.8% | $1B-0.5% | $1.03B+0.6% | $984.17M-2.7% | ||
| $159.42M-10.3% | $196.14M+0.2% | $177.59M-10.9% | $191.55M+12.8% | $177.8M-4.6% | ||
| $119.9M+60.6% | —— | $133.8M+14.0% | $100.13M-34.0% | $74.67M-40.7% | ||
| 12%+4.5pp | —— | 13.3%+1.7pp | 9.7%-5.1pp | 7.6%-4.9pp | ||
| $26.74M-4.1% | $23.78M-15.8% | $25.4M-16.1% | $29.97M-8.6% | $27.88M-20.3% | ||
| -$124.13M-917% | —— | -$22.62M-973% | $154K+107% | -$12.21M-309% | ||
| -$15.14M-250% | —— | $31.64M+51.1% | $18.73M-26.3% | $10.1M-58.8% | ||
| -$14.84M-158% | -$276.56M— | $54.42M-21.9% | $52.33M-44.4% | $25.47M-65.1% | ||
| -1.5%-4.1pp | -27.8%— | 5.4%-1.5pp | 5.1%-4.1pp | 2.6%-4.6pp | ||
| -$0.30-160% | -$5.56— | $1.10-17.3% | $1.06-39.1% | $0.50-61.5% | ||
| $187.05M-4.1% | $77.18M-49.8% | $218.96M+6.5% | $219.64M-7.6% | $195.03M-7.7% | ||
| 18.8%-1.0pp | 7.8%-7.6pp | 21.8%+1.4pp | 21.3%-1.9pp | 19.8%-1.1pp | ||
| $119.9M+60.6% | -$1.1M-102% | $133.8M+14.0% | $100.13M-34.0% | $74.67M-40.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Charles River Laboratories's revenue?
- Charles River Laboratories (CRL) generated $4.0B in revenue over the trailing twelve months, up 0.1% year over year.
- Is Charles River Laboratories profitable?
- Charles River Laboratories is not currently profitable: it reported a net loss of $184.7M over the trailing twelve months, a -4.6% net margin.
- What are Charles River Laboratories's profit margins?
- Gross margin is 84.7% and operating margin is 13.0%, with a -4.6% net margin.
- What is Charles River Laboratories's earnings per share?
- Charles River Laboratories's diluted EPS over the trailing twelve months is $-3.70.
- Where does Charles River Laboratories's income statement data come from?
- Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
